3/12
10:12 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
3/12
10:12 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
3/12
09:54 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX
3/12
09:54 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX
2/26
11:36 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Medium
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
2/26
11:36 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Medium
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
2/26
11:09 am
pcvx
Rating for PCVX
Medium
Report
Rating for PCVX
2/26
11:09 am
pcvx
Rating for PCVX
Medium
Report
Rating for PCVX
2/26
08:00 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.
2/26
07:36 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX
2/26
07:36 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX
2/11
08:09 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
2/11
07:15 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX
2/11
07:15 am
pcvx
Rating for PCVX
Low
Report
Rating for PCVX